- Home
- OTLK vs EDRY Comparison
OTLK vs EDRY Comparison
Compare OTLK & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- EDRY
- Stock Information
- Founded
- OTLK 2010
- EDRY 2018
- Country
- OTLK United States
- EDRY Greece
- Employees
- OTLK N/A
- EDRY N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- EDRY Marine Transportation
- Sector
- OTLK Health Care
- EDRY Consumer Discretionary
- Exchange
- OTLK Nasdaq
- EDRY Nasdaq
- Market Cap
- OTLK 48.3M
- EDRY 25.2M
- IPO Year
- OTLK 2016
- EDRY N/A
- Fundamental
- Price
- OTLK $1.57
- EDRY $9.67
- Analyst Decision
- OTLK Strong Buy
- EDRY
- Analyst Count
- OTLK 5
- EDRY 0
- Target Price
- OTLK $9.60
- EDRY N/A
- AVG Volume (30 Days)
- OTLK 796.7K
- EDRY 7.7K
- Earning Date
- OTLK 08-13-2025
- EDRY 06-05-2025
- Dividend Yield
- OTLK N/A
- EDRY N/A
- EPS Growth
- OTLK N/A
- EDRY N/A
- EPS
- OTLK 0.83
- EDRY N/A
- Revenue
- OTLK N/A
- EDRY $55,867,583.00
- Revenue This Year
- OTLK N/A
- EDRY N/A
- Revenue Next Year
- OTLK $379.84
- EDRY $28.27
- P/E Ratio
- OTLK $1.91
- EDRY N/A
- Revenue Growth
- OTLK N/A
- EDRY 10.25
- 52 Week Low
- OTLK $0.87
- EDRY $7.60
- 52 Week High
- OTLK $9.25
- EDRY $24.79
- Technical
- Relative Strength Index (RSI)
- OTLK 40.37
- EDRY 61.17
- Support Level
- OTLK $1.65
- EDRY $8.95
- Resistance Level
- OTLK $2.04
- EDRY $11.85
- Average True Range (ATR)
- OTLK 0.12
- EDRY 0.55
- MACD
- OTLK -0.03
- EDRY 0.09
- Stochastic Oscillator
- OTLK 2.13
- EDRY 35.11
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.